At the start of the COVID-19 pandemic, Yale scientists worked as quickly as possible to understand how to fight the SARS-CoV-2 virus, reimagining their work to best address the new, rapidly evolving deadly pathogen.
Now, thanks to an investment from the Howard Hughes Medical Institute, two labs at Yale will be leading collaborative research projects working to get a “scientific head start” on future epidemics.
One team, headed by Richard Flavell, Sterling Professor of Immunobiology, will look at vaccine development, while another, led by Anna Pyle, Sterling Professor of Molecular, Cellular & Developmental Biology, will examine new technologies to create RNA vaccines.